Mesoblast Ltd Ord

(MEOBF)

By |

Profile

Mesoblast is developing adult stem cell therapies based on its proprietary mesenchymal precursor stem cell and culture-expanded mesenchymal stem cell technology platforms. It has nine clinical trial programs across four major areas (cardiovascular, spine disease, immunologic/inflammatory, and cancer) targeting chronic diseases affecting large populations.

Contact Information

Website: www.mesoblast.com
Email: michael.schuster@mesoblast.com
Main Phone: +61 396396036
Address: Level 38, 55 Collins Street
State: VIC
City / Town: Melbourne
Country: AUS
Postal Code: 3000

Issuer Information

Exchange: OTO
CEO: Silviu Itescu
Employees: 81
NAICS: 541711
$ 1.02 $ 0. (0.00%)
Last Price 1.02 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 1.02
Last Trade Volume 0 52 Wk Hi 1.75 52 Wk Low 0.95
Market Cap 492.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 482,901,654.00 EPS (TTM) -0.10 PE Ratio N/A Exchange OTCPK